Senseonics Holdings, Inc. (NYSE:SENS) to Post Q1 2024 Earnings of ($0.03) Per Share, HC Wainwright Forecasts

Senseonics Holdings, Inc. (NYSE:SENSFree Report) – Equities research analysts at HC Wainwright issued their Q1 2024 earnings per share estimates for Senseonics in a report released on Monday, March 11th. HC Wainwright analyst V. Bernardino expects that the company will post earnings of ($0.03) per share for the quarter. HC Wainwright has a “Buy” rating and a $2.00 price objective on the stock. The consensus estimate for Senseonics’ current full-year earnings is ($0.12) per share. HC Wainwright also issued estimates for Senseonics’ Q2 2024 earnings at ($0.03) EPS, Q3 2024 earnings at ($0.03) EPS and Q4 2024 earnings at ($0.03) EPS.

SENS has been the topic of several other research reports. TheStreet downgraded Senseonics from a “c-” rating to a “d” rating in a report on Friday, November 17th. StockNews.com raised Senseonics to a “sell” rating in a report on Tuesday, November 14th.

Read Our Latest Analysis on SENS

Senseonics Stock Up 0.9 %

NYSE:SENS opened at $0.61 on Wednesday. The stock’s fifty day moving average price is $0.59. Senseonics has a 52-week low of $0.46 and a 52-week high of $1.05. The company has a debt-to-equity ratio of 1.15, a quick ratio of 7.03 and a current ratio of 7.53.

Senseonics (NYSE:SENSGet Free Report) last announced its earnings results on Thursday, February 29th. The company reported ($0.03) EPS for the quarter, topping the consensus estimate of ($0.04) by $0.01. The business had revenue of $8.00 million for the quarter, compared to the consensus estimate of $7.62 million. Senseonics had a negative return on equity of 146.90% and a negative net margin of 270.13%.

Institutional Trading of Senseonics

Large investors have recently made changes to their positions in the company. Magnolia Capital Advisors LLC bought a new stake in shares of Senseonics in the 4th quarter valued at $26,000. Alan B Lancz & Associates Inc. bought a new stake in shares of Senseonics in the 2nd quarter valued at $26,000. CTC Alternative Strategies Ltd. bought a new stake in shares of Senseonics in the 2nd quarter valued at $31,000. Cornerstone Wealth Management LLC increased its holdings in Senseonics by 55.9% during the 3rd quarter. Cornerstone Wealth Management LLC now owns 55,750 shares of the company’s stock worth $34,000 after purchasing an additional 20,000 shares in the last quarter. Finally, RPO LLC bought a new position in Senseonics during the 4th quarter worth about $37,000. Institutional investors own 16.59% of the company’s stock.

About Senseonics

(Get Free Report)

Senseonics Holdings, Inc, a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense, Eversense XL, and Eversense E3 which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months.

Further Reading

Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.